---
schema_version: "secwatch.filing_event.v1"
accession: "0001792044-26-000037"
form_type: "8-K"
ticker: "VTRS"
cik: "0001792044"
company_name: "Viatris Inc"
filed_at: "2026-08-06T11:56:03+00:00"
generated_at: "2026-08-06T12:00:15.470223+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Viatris Q2 2026: Revenue $3.8B (+5%), GAAP net loss $119M, raises full-year guidance

## Summary
- Total revenues $3.8B, up 5% reported and 3.5% operationally vs Q2 2025; GAAP net loss $119M.
- Adjusted EBITDA $1.2B, up 8% operationally; gross leverage ratio reduced to 2.9x.
- Raised 2026 financial guidance midpoints for all metrics; expects balanced H2.
- Returned ~$550M to shareholders including ~$270M share repurchases through early August.
- Pipeline milestones: U.S. FDA approval of Gwyn Lo; sale of global rights to Tyrvaya.

## SEC filing metadata
- accession: 0001792044-26-000037
- form_type: 8-K
- ticker: VTRS
- cik: 0001792044
- company_name: Viatris Inc
- filed_at: 2026-08-06T11:56:03+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792044/000179204426000037/0001792044-26-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792044/000179204426000037/vtrs-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001792044-26-000037
- JSON: https://secwatch.observer/filing/0001792044-26-000037.json
- Plain text: https://secwatch.observer/filing/0001792044-26-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.